
Considering How TAILORx Transformed Node-Negative Breast Cancer Treatment
Node-negative, hormone receptor–positive/HER2-negative breast cancer represents a subset of patients where treatment decisions often hinge on genomic risk stratification. Heather L. McArthur, MD, MPH, an associate professor in the Department of …